Task A15: In vitro screening for antibacterial activity against public health disease pathogens

任务 A15：针对公共卫生疾病病原体的抗菌活性的体外筛选

• 批准号: 10551059
• 负责人: THOMAS PATTERSON
• 金额: $ 2.1万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-27 至 2022-07-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10551059
• 关键词: Acinetobacter; Advanced Development; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Resistance; Bacteria; Biological Assay; Contracts; Development; Disease; Enterobacter; Enterococcus; In Vitro; Klebsiella; Maintenance; Mycotoxins; Proteus; Pseudomonas aeruginosa; Public Health; Staphylococcus aureus; Stenotrophomonas; Streptococcus; Toxin; combat; fungus; in vitro testing; pathogen; pathogenic Escherichia coli; screening; therapeutic development

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

该合同提供了对潜在抗菌和抗真菌药物的体外测试，可抵抗细菌和真菌产生的毒素作用的功效，细菌，真菌和毒素种群的维持以及相关测定的开发。